El Vínculo El Vínculo.
Awarded European Union Services

Tumor profiling test for breast cancer

Buyer: HUS-yhtymä

Published
29 July 2025
Estimated value
€1,870,000
Procedure
Restricted procedure
Lots
1
Notice number
00495608-2025
Reference
c8250e10-a926-4a75-82c6-2319a9a5bf63
Official source
Official source

CPV codes

Description

The Procurement Entities HUS and ISLAB asked for tenders for the subcontracting service of gene expression based tumor profiling test for breast cancer. The test was intended to be used in risk classification of patients with hormone receptor-positive (ER+), HER2 (human epidermal growth factor receptor 2) negative breast cancer, when considering the initiation of chemotherapy. The test should provide both a predictive and prognostic tool to estimate a patient’s risk of distant breast-cancer recurrence. The tumor profiling test must demonstrably improve the risk classification of patients and identify those patients who will benefit the most from chemotherapy.

Award criteria

Awards

Awarded toAmountDate
Genomic Health, Inc. €1,870,000

Official publications

Other tenders from HUS-yhtymä

Frequently asked questions

What is the estimated value of this tender?
The estimated value published by the buyer is €1,870,000.
Who is the buyer of this tender?
The contracting authority is HUS-yhtymä (European Union).
How can I bid for public tenders in European Union?
Bids are submitted through the official procurement portal of European Union. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.
Get alerts for tenders like this
Create a free account and receive new tenders from European Union matching your business, every day.

Start for free

Data collected from official public procurement sources. Amounts as published by the buyer.